| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief R&D Officer | SVP Clinical Development, CMO | VP Clinical Development, CMO
2 companies
Thackray Helen M. serves as a Chief R&D Officer at BCRX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 13 sells. Those positions are worth an estimated $2.8M at current prices.
Historically, Thackray Helen M.'s trades have earned a strong insider score of 78/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +55.1%.
The biggest single holding is BCRX (~$2.8M) as Chief R&D Officer. Net of sales, the recent Form 4 record there shows accumulation of 12,275 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | BCRX Biocryst Pharmaceuticals Inc | Chief R&D Officer | Buy | 30,000 | $5.86 | $175,800.00 | +12.4% | +44.2% | +83.8% | |
| Apr 3, 2023 | BCRX Biocryst Pharmaceuticals Inc | Chief R&D Officer | Sell | 7,000 | $8.29 | $58,030.00 | -3.3% | -15.8% | -44.0% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Chief R&D Officer | Sell | 3,125 | $10.89 | $34,031.25 | -2.3% | -22.6% | -42.7% | |
| Apr 1, 2022 | BCRX Biocryst Pharmaceuticals Inc | Chief R&D Officer | Sell | 7,600 | $16.20 | $123,120.00 | -5.3% | -36.2% | -49.7% | |
| Dec 8, 2017 | CBIO Crescent Biopharma, Inc. | SVP Clinical Development, CMO | Sell | 2,000 | $15.01 | $30,020.00 | -1.3% | - | - | |
| Sep 18, 2017 | CBIO Crescent Biopharma, Inc. | SVP Clinical Development, CMO | Sell | 2,000 | $13.00 | $26,000.00 | -1.3% | - | - | |
| May 25, 2017 | CBIO Crescent Biopharma, Inc. | SVP Clinical Development, CMO | Sell | 2,000 | $15.57 | $31,140.00 | -1.3% | - | - | |
| May 19, 2017 | CBIO Crescent Biopharma, Inc. | SVP Clinical Development, CMO | Sell | 2,000 | $12.14 | $24,280.00 | -1.3% | - | - | |
| Oct 3, 2016 | CBIO Crescent Biopharma, Inc. | VP Clinical Development, CMO | Sell | 4,000 | $7.00 | $28,001.00 | -2.5% | - | - | |
| Jul 20, 2016 | CBIO Crescent Biopharma, Inc. | VP Clinical Development, CMO | Sell | 2,000 | $8.00 | $16,000.00 | -1.2% | - | - |